Stockreport

Barclays Adjusts Elevance Health (ELV) PT to $393 While Maintaining Overweight Rating [Yahoo! Finance]

Elevance Health, Inc.  (ELV) 
PDF price target on Elevance Health to $393 from $404 and kept an Overweight rating on the shares. On January 29, Guggenheim analyst Jason Cassorla also lowered the firm's [Read more]